ABM Therapeutics Corporation
2 clinical trials · Sponsor
◉ Watch ABM Therapeutics Corporation
| Record | Firm | Date |
|---|---|---|
| Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors. (NCT05831995) | ABM Therapeutics Corporation | 2023-03-30 |
| Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors (NCT04190628) | ABM Therapeutics Corporation | 2020-06-16 |
Track ABM Therapeutics Corporation automatically
Every clearance here is in the API, with alerts when new ones post.